09
May
Open Letter on behalf of the European Virus Archive (EVA) to the Intergovernmental Negotiating Body (INB) of the WHO CA+
Abstract ... read more
The EVA-GLOBAL community supports fair and equitable benefit sharing as conceived in various United Nations frameworks.
The consortium is actively implementing a CBD/Nagoya Protocol compliance strategy.
A European project infrastructure,
global Non-profit organisation for sharing viral material within the scientific community
global Non-profit organisation for sharing viral material within the scientific community
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 871029
![5000100-flag[1].jpg](https://cdn.european-virus-archive.com/sites/default/files/5000100-flag%5B1%5D.jpg)
European Virus Archive
EVA
Now ................................ goes Global
STILL
PROVIDING
VIRUSES AND DERIVED PRODUCTS :)
g
The
X
is
- GLOBAL
JOIN US
Share within the scientific community
EVA GLOBAL
is the most important biological resource in the field of virology...worldwide
EVA-GLOBAL is an open entity aiming at developing synergies and complementary capabilities
Need a teammate...?
EVA-GLOBAL provides you with high quality viruses and derived products
The best way to get viral material within the Scientific Community. Browse our viruses and derived products from the EVAg Portal.
EVAg is a non profit organisation that mobilises a global network with expertise in virology to collect amplify characterise standardise authenticate distribute track viruses and derived products.
A unique biological resource in the field of virology, readily available online. Users may benefit from special funding to access to products of interest, do not hesitate to apply.
A network of laboratories
An international group of 25 laboratories, including 16 EU member state institutions and 9 non-EU institutions, that represent an extensive range of virological disciplines.
Collaborations
An open entity aiming at developing synergies and complementary capabilities in such a way as to offer an improved access to researchers.
Quality
The quality of viruses and derived products is a key consideration when our products are to be made available. Improvements on quality process will be addressed during the project.
Preparedness and Response
EVAg generates and distributes globally diagnostic materials and protocols in the event of epidemiological emergencies.
Research
Focused on the creation of new tools, techniques and concepts to develop the infrastructure and to provide easier and less expensive access to virological materials.
Online Catalogue
A user-friendly web Portal with a continuously increasing number of viruses and derived products. Start here...
The EVAg initiative will increase competitiveness and, provides for a strong interaction with industry and a promising foundation for the innovation process between academia and industry.
- The European Commission -
The initiative has an important social impact with particular emphasis on human disease.
- The European Commission -
The quality of the installations cooperating in this consortium is excellent, representing some of the best available infrastructures across the EU and world-wide.
- The European Commission -
